Viewing Study NCT01621256


Ignite Creation Date: 2025-12-24 @ 11:19 PM
Ignite Modification Date: 2025-12-25 @ 9:00 PM
Study NCT ID: NCT01621256
Status: COMPLETED
Last Update Posted: 2018-12-21
First Post: 2012-06-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss
Sponsor: Nordmark Arzneimittel GmbH & Co. KG
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module